Safeguarding patients in clinical trials with high mortality rates

被引：51
作者：
Freeman, BD
Danner, RL
Banks, SM
Natanson, C
机构：
[1] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[2] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2001年 / 164卷 / 02期
关键词：
D O I：
10.1164/ajrccm.164.2.2011028
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：190 / 192
页数：3
相关论文
共 21 条
  • [1] BENGISSON BA, 1999, LANCET, V354, P2222
  • [2] DIFFERENTIAL HEMODYNAMIC-EFFECTS OF L-NMMA IN ENDOTOXEMIC AND NORMAL DOGS
    COBB, JP
    NATANSON, C
    QUEZADO, ZMN
    HOFFMAN, WD
    KOEV, CA
    BANKS, S
    CORREA, R
    LEVI, R
    ELIN, RJ
    HOSSEINI, JM
    DANNER, RL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (04): : H1634 - H1642
  • [3] The agonising negative trend in monitoring of clinical trials
    DeMets, DL
    Pocock, SJ
    Julian, DG
    [J]. LANCET, 1999, 354 (9194) : 1983 - 1988
  • [4] Growth hormone therapy in critically ill patients
    Demling, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) : 837 - 839
  • [5] Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock
    Grover, R
    Lopez, A
    Lorente, J
    Steingrub, J
    Bakker, J
    Willatts, S
    McLuckie, A
    Takala, J
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (01) : A33 - A33
  • [6] An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyI-L-arginine hydrochloride (546C88), in patients with septic shock
    Grover, R
    Zaccardelli, D
    Colice, G
    Guntupalli, K
    Watson, D
    Vincent, JL
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (05) : 913 - 922
  • [7] GROVER R, 1998, CRIT CARE MED S, V26, pA29
  • [8] Dose-dependent effect of diaspirin cross-linked hemoglobin on regional blood circulation of severely hemorrhaged rats
    Gulati, A
    Sen, AP
    [J]. SHOCK, 1998, 9 (01): : 65 - 73
  • [9] Pharmacokinetics of the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride in patients with septic shock
    Hussein, Z
    Beerahee, M
    Grover, R
    Jordan, B
    Jeffs, R
    Donaldson, J
    Zaccardelli, D
    Colice, G
    Guntupalli, K
    Watson, D
    Vincent, JL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (01) : 1 - 9
  • [10] KNOX J, 1995, J TRAUMA, V39, P526
123